Theralase Technologies Stock Shares Owned By Institutions

Understanding the fundamental principles of building solid financial models for Theralase Technologies is extremely important. It helps to project a fair market value of Theralase Stock properly, considering its historical fundamentals such as Shares Owned By Institutions. Since Theralase Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Theralase Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Theralase Technologies' interrelated accounts and indicators.

Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Based on the latest financial disclosure, 0.0% of Theralase Technologies are shares owned by institutions. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The shares owned by institutions for all Canada stocks is 100.0% higher than that of the company.

We derive many important indicators used in calculating different scores of Theralase Technologies from analyzing Theralase Technologies' financial statements. These drivers represent accounts that assess Theralase Technologies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Theralase Technologies' important valuation drivers and their relationship over time.

The Macroaxis Fundamental Analysis modules help investors analyze Theralase Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theralase Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theralase Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.